| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |